Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 33,779 | reported | 27 Aug 2021 | tx 11+498,898−175,558 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Aug 2021 | EXERCISE | Kymera Therapeutics, Inc. | 33,779 | 20.00 USD | |
| 27 Aug 2021 | SALE | Kymera Therapeutics, Inc. | 33,779 | 60.12 USD | |
| 27 Aug 2021 | EXERCISE | Kymera Therapeutics, Inc. | 33,779 | 0.00 USD | deriv |
| 17 Aug 2021 | SALE | Kymera Therapeutics, Inc. | 288 | 52.09 USD | |
| 17 Aug 2021 | SALE | Kymera Therapeutics, Inc. | 2,928 | 51.68 USD | |
| 17 Aug 2021 | SALE | Kymera Therapeutics, Inc. | 41,975 | 50.37 USD | |
| 17 Aug 2021 | SALE | Kymera Therapeutics, Inc. | 8,809 | 49.90 USD | |
| 17 Aug 2021 | EXERCISE | Kymera Therapeutics, Inc. | 54,000 | 20.00 USD | |
| 17 Aug 2021 | EXERCISE | Kymera Therapeutics, Inc. | 54,000 | 0.00 USD | deriv |
| 01 Mar 2021 | GRANT_AWARD | Kymera Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 20 Aug 2020 | GRANT_AWARD | Kymera Therapeutics, Inc. | 351,119 | 0.00 USD | deriv |